-
Oculus Innovative Sciences Gains 23%, Company Receives European Approval To Market Sinudox
Wednesday, April 13, 2016 - 9:13am | 287Read More...Shares of Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), a nano-cap specialty device and pharmaceutical company that focuses on the treatment of dermatological conditions, were trading higher by more than 23 percent early Wednesday morning. Oculus announced that it has received European approval...
-
LifeTech Capital Maintains Strong Buy on Oculus Innovative Sciences
Monday, June 13, 2011 - 9:13am | 82Read More...LifeTech Capital is out with its report today on Oculus Innovative Sciences (NASDAQ: OCLS), maintaining Strong Buy. In a note to clients, LifeTech Capital writes, "We believe shares of Oculus Innovative Sciences are undervalued and are maintaining Oculus with a Strong Buy rating and a 12-18 month...

